Baixar PDF

Outros usuários também visualizaram estes artigos

OPTIMIZATION OF IMID-BASED THERAPIES Murat ǿnarsoy;
Hematol Transfus Cell Ther. 2024;46 Supl 7:S1
LONG-ACTING ZOLEDRONIC ACID: ONCE-YEARLY ADMINISTRATION AND EFFICACY EVALUATION IN MYELOMA BONE DISEASE Murat ǿnarsoy;
Hematol Transfus Cell Ther. 2024;46 Supl 7:S59-60
THE RELATIONSHIP BETWEEN FERRITIN LEVEL AND THROMBOSIS IN PATIENTS WITH DIFFUSE LARGE B-CELL LYMPHOMA Bu¿ra Sa¿lam; Murat Albayrak; Abdulkerim Y¿ld¿z; P¿nar T¿pl¿o¿lu; Mesut T¿¿l¿o¿lu; Merih Reis Aras; Fatma Y¿lmaz; Hacer Berna Afacan Öztürk;
Hematol Transfus Cell Ther. 2022;44 Supl 1:S31